Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Feb;22(2):375-377.
doi: 10.1002/ejhf.1662. Epub 2019 Nov 27.

Heart failure after treatment for breast cancer: old cancer therapies, new clinical data. What do we need to complete the puzzle?

Affiliations
Free article
Editorial

Heart failure after treatment for breast cancer: old cancer therapies, new clinical data. What do we need to complete the puzzle?

Teresa López-Fernández et al. Eur J Heart Fail. 2020 Feb.
Free article
No abstract available

PubMed Disclaimer

Comment on

  • Heart failure after treatment for breast cancer.
    Boekel NB, Duane FK, Jacobse JN, Hauptmann M, Schaapveld M, Sonke GS, Gietema JA, Hooning MJ, Seynaeve CM, Maas AHEM, Darby SC, Aleman BMP, Taylor CW, van Leeuwen FE. Boekel NB, et al. Eur J Heart Fail. 2020 Feb;22(2):366-374. doi: 10.1002/ejhf.1620. Epub 2019 Nov 12. Eur J Heart Fail. 2020. PMID: 31721395 Free PMC article.

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424.
    1. Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, Habib G, Lenihan DJ, Lip GYH, Lyon AR, Lopez Fernandez T, Mohty D, Piepoli MF, Tamargo J, Torbicki A, Suter TM; ESC Scientific Document Group. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. Eur J Heart Fail 2017;19:9-42.
    1. López-Fernández T, Martín García A, Santaballa Beltrán A, Montero Luis Á, García Sanz R, Mazón Ramos P, Velasco Del Castillo S, López de Sá Areses E, Barreiro-Pérez M, Hinojar Baydes R, Pérez de Isla L, Valbuena López SC, Dalmau González-Gallarza R, Calvo-Iglesias F, González Ferrer J, Castro Fernández A, González-Caballero E, Mitroi C, Arenas M, Virizuela Echaburu JA, Marco Vera P, Íñiguez Romo A, Zamorano JL, Plana Gómez JC, López-Sendón J. Cardio-onco-hematology in clinical practice. Position paper and recommendations. Rev Esp Cardiol 2017;70:474-486.
    1. Cardoso F, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rubio IT, Zackrisson S, Senkus E; on behalf of the ESMO Guidelines Committee. Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2019;30:1194-1220.
    1. Mehta LS, Watson KE, Barac A, Beckie TM, Bittner V, Cruz-Flores S, Dent S, Kondapalli L, Ky B, Okwuosa T, Piña IL, Volgman AS. Cardiovascular disease and breast cancer: where these entities intersect. A scientific statement from the American Heart Association, American Heart Association Cardiovascular Disease in Women and Special Populations Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing, and Council on Quality of Care and Outcomes Research. Circulation 2018;137:e30-e66.

LinkOut - more resources